<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7044301</article-id><article-id pub-id-type="publisher-id">59944</article-id><article-id pub-id-type="doi">10.1038/s41598-020-59944-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Characterisation of HIV-1 Molecular Epidemiology in Nigeria: Origin, Diversity, Demography and Geographic Spread</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9029-7976</contrib-id><name><surname>Nazziwa</surname><given-names>Jamirah</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9747-8822</contrib-id><name><surname>Faria</surname><given-names>Nuno Rodrigues</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Chaplin</surname><given-names>Beth</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Rawizza</surname><given-names>Holly</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kanki</surname><given-names>Phyllis</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Dakum</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Abimiku</surname><given-names>Alash&#x02019;le</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Charurat</surname><given-names>Man</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9498-3428</contrib-id><name><surname>Ndembi</surname><given-names>Nicaise</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6088-7796</contrib-id><name><surname>Esbj&#x000f6;rnsson</surname><given-names>Joakim</given-names></name><address><email>joakim.esbjornsson@med.lu.se</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0930 2361</institution-id><institution-id institution-id-type="GRID">grid.4514.4</institution-id><institution>Department of Translational Medicine, </institution><institution>Lund University, </institution></institution-wrap>Lund, Sweden </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution>Department of Zoology, </institution><institution>University of Oxford, </institution></institution-wrap>Oxford, United Kingdom </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution>Department of Immunology and Infectious Diseases, </institution><institution>Harvard T.H. Chan School of Public Health, </institution></institution-wrap>Boston, USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.421160.0</institution-id><institution>Institute of Human Virology Nigeria, </institution></institution-wrap>Abuja, Nigeria </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2175 4264</institution-id><institution-id institution-id-type="GRID">grid.411024.2</institution-id><institution>Institute of Human Virology, </institution><institution>University of Maryland School of Medicine, </institution></institution-wrap>Baltimore, USA </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution>Nuffield Department Medicine, </institution><institution>University of Oxford, </institution></institution-wrap>Oxford, United Kingdom </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>2</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>2</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>10</volume><elocation-id>3468</elocation-id><history><date date-type="received"><day>5</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>5</day><month>2</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Nigeria has the highest number of AIDS-related deaths in the world. In this study, we characterised the HIV-1 molecular epidemiology by analysing 1442 HIV-1 <italic>pol</italic> sequences collected 1999&#x02013;2014 from four geopolitical zones in Nigeria using state-of-the-art maximum-likelihood and Bayesian phylogenetic analyses. The main circulating forms were the circulating recombinant form (CRF) 02_AG (44% of the analysed sequences), CRF43_02G (16%), and subtype G (8%). Twenty-three percent of the sequences represented unique recombinant forms (URFs), whereof 37 (11%) could be grouped into seven potentially novel CRFs. Bayesian phylodynamic analysis suggested that five major Nigerian HIV-1 sub-epidemics were introduced in the 1960s and 1970s, close to the Nigerian Civil War. The analysis also indicated that the number of effective infections decreased in Nigeria after the introduction of free antiretroviral treatment in 2006. Finally, Bayesian phylogeographic analysis suggested gravity-like dynamics in which virus lineages first emerge and expand within large urban centers such as Abuja and Lagos, before migrating towards smaller rural areas. This study provides novel insight into the Nigerian HIV-1 epidemic and may have implications for future HIV-1 prevention strategies in Nigeria and other severely affected countries.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>HIV infections</kwd><kwd>Viral infection</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsr&#x000e5;det (Swedish Research Council)</institution></institution-wrap></funding-source><award-id>350-2012-6628</award-id><award-id>2016-01417</award-id><principal-award-recipient><name><surname>Esbj&#x000f6;rnsson</surname><given-names>Joakim</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100006738</institution-id><institution>Lund University | Medicinska Fakulteten, Lunds Universitet (Faculty of Medicine, Lund University)</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Thirty-eight years after the first AIDS case was described, HIV-1 remains a major public health problem that affects approximately 36.7 (30.8&#x02013;42.9) million people globally<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. Sub-Saharan Africa accounts for approximately 70% of all infections. In addition, HIV-1 represent one of the most fast-evolving pathogens known to science. This has led to the classification of HIV-1 into subtypes, sub-subtypes and circulating recombinant forms (CRFs). Of relevance, previous reports have suggested that the genetic composition of the infecting HIV-1 strain may influence transmission, disease progression, virus-host interactions, antiretroviral treatment responses, and vaccine development<sup><xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref></sup>. Moreover, it has been suggested that targeted HIV-1 prevention may be a cost-effective way to decrease the number of new HIV-1 infections &#x02013; not least in low-and-middle-income countries<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Planning of such HIV-1 intervention programs will require detailed information about both the characteristics and sources of new infections.</p><p id="Par3">Nigeria is the most populous country in Sub-Saharan Africa, has the second highest number of HIV-1 infected persons in the world, and the highest number of annual AIDS-related deaths<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>. HIV-1 serological surveys in Nigeria were initiated in 1991, at which time the adult prevalence was 1.8% (760000 people)<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. This figure increased to 5.8% by 2001 (2.6 million), before declining to 2.8% in 2017 (3.1 million)<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>. Previous reports have identified subtype G and the CRF02_AG as the most common HIV-1 variants in Nigeria<sup><xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref></sup>. In addition, the CRF43_02G was recently shown to be highly prevalent in the capital Abuja<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. However, the estimates of each strain&#x02019;s contribution to the Nigerian HIV-1 epidemic have varied considerably, with frequency estimates ranging from 22&#x02013;50% for subtype G, and 19&#x02013;60% for the CRF02_AG<sup><xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref></sup>. These variations could have several reasons, such as differences between geographic areas, transmission groups, or employed subtyping tools<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. Hence, a clearer picture of the HIV-1 subtype/CRF distributions and spread in Nigeria is needed. The objective of the current study was therefore to perform the first nationwide analysis of the molecular epidemiology of HIV-1 in Nigeria.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Sequence dataset</title><p id="Par4">We analyzed 366 previously unpublished HIV-1 <italic>pol</italic> sequences (positions in HXB2 K03455: 2253&#x02013;3364) collected in Abuja, Nigeria between 2006&#x02013;2011, together with all Nigerian <italic>pol</italic> sequences from the corresponding genetic region available in the Los Alamos HIV-1 sequence database (N&#x02009;=&#x02009;1076, <ext-link ext-link-type="uri" xlink:href="http://www.hiv.lanl.gov/">http://www.hiv.lanl.gov/</ext-link>, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). All sequences without date and location of sampling were excluded. However, contact with all relevant research centers was made in order to obtain such missing information.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Proportion of subtype/CRF in the Nigerian dataset of previously published and new sequences collected in the period 1999&#x02013;2013.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Subtype/CRF<sup>a</sup></th><th rowspan="3">N<sup>c</sup></th><th rowspan="3">%</th><th colspan="18">Geography<sup>d</sup></th></tr><tr><th colspan="7">Southwest</th><th colspan="5">North Central</th><th colspan="6">North East &#x00026; North West</th></tr><tr><th>LAG</th><th>IBA</th><th>OND</th><th>OSO</th><th>OYO</th><th>ENU</th><th>Total</th><th>ABV</th><th>JOS</th><th>MIN</th><th>NC</th><th>Total</th><th>KAD</th><th>DAM</th><th>MAI</th><th>KAN</th><th>YOL</th><th>Total</th></tr></thead><tbody><tr><td>A1</td><td>24</td><td>1.7</td><td>9</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>11</bold></td><td>7</td><td>5</td><td>0</td><td>0</td><td><bold>12</bold></td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td><td><bold>1</bold></td></tr><tr><td>B</td><td>4</td><td>0.3</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>2</bold></td><td>2</td><td>0</td><td>0</td><td>0</td><td><bold>2</bold></td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td></tr><tr><td>C</td><td>14</td><td>1.0</td><td>2</td><td>1</td><td>0</td><td>0</td><td>2</td><td>0</td><td><bold>5</bold></td><td>6</td><td>2</td><td>0</td><td>1</td><td><bold>9</bold></td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td></tr><tr><td>CRF02_AG</td><td>636</td><td>44.1</td><td>176</td><td>27</td><td>0</td><td>1</td><td>18</td><td>0</td><td><bold>222</bold></td><td>284</td><td>94</td><td>0</td><td>10</td><td><bold>388</bold></td><td>13</td><td>0</td><td>11</td><td>2</td><td>0</td><td><bold>26</bold></td></tr><tr><td>CRF06_cpx</td><td>64</td><td>4.4</td><td>18</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>20</bold></td><td>36</td><td>6</td><td>0</td><td>1</td><td><bold>43</bold></td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td><td><bold>1</bold></td></tr><tr><td>CRF09_cpx</td><td>1</td><td>0.1</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>1</bold></td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td></tr><tr><td>CRF11_cpx</td><td>4</td><td>0.3</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>1</bold></td><td>2</td><td>1</td><td>0</td><td>0</td><td><bold>3</bold></td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td></tr><tr><td>CRF18_cpx</td><td>1</td><td>0.1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>1</bold></td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td></tr><tr><td>CRF19_cpx</td><td>1</td><td>0.1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td><td>0</td><td>1</td><td>0</td><td>0</td><td><bold>1</bold></td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td></tr><tr><td>CRF43_02G</td><td>236</td><td>16.4</td><td>33</td><td>11</td><td>1</td><td>0</td><td>0</td><td>0</td><td><bold>45</bold></td><td>138</td><td>34</td><td>0</td><td>0</td><td><bold>172</bold></td><td>8</td><td>0</td><td>8</td><td>3</td><td>0</td><td><bold>19</bold></td></tr><tr><td>CRF49_cpx</td><td>1</td><td>0.1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>1</bold></td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>0</bold></td></tr><tr><td>D</td><td>9</td><td>0.6</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>2</bold></td><td>4</td><td>2</td><td>0</td><td>0</td><td><bold>6</bold></td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td><td><bold>1</bold></td></tr><tr><td>G</td><td>119</td><td>8.3</td><td>24</td><td>6</td><td>0</td><td>0</td><td>0</td><td>0</td><td><bold>30</bold></td><td>55</td><td>25</td><td>1</td><td>0</td><td><bold>81</bold></td><td>4</td><td>1</td><td>3</td><td>0</td><td>0</td><td><bold>8</bold></td></tr><tr><td>URF<sup>b</sup></td><td>328</td><td>22.7</td><td>78</td><td>13</td><td>0</td><td>0</td><td>2</td><td>1</td><td><bold>94</bold></td><td>163</td><td>46</td><td>0</td><td>3</td><td><bold>212</bold></td><td>9</td><td>0</td><td>11</td><td>0</td><td>2</td><td><bold>22</bold></td></tr><tr><td>Total</td><td><bold>1442</bold></td><td>100</td><td>346</td><td>64</td><td>1</td><td>1</td><td>22</td><td>1</td><td><bold>435</bold></td><td>697</td><td>216</td><td>1</td><td>15</td><td><bold>929</bold></td><td>34</td><td>1</td><td>35</td><td>5</td><td>2</td><td><bold>78</bold></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>CRF, Circulating recombinant forms; <sup>b</sup>URF, Unique recombinant forms; <sup>c</sup>N, number of sequences; <sup>d</sup>Abbreviations for the different cities: LAG, Lagos; IBA, Ibadan; OND, Ondo; OSO, Osogbo; OYO, Oyo; ENU, Enugu; ABV, Abuja; JOS, Jos; MIN, Minna; NC, Other North central cities; KAD, Kaduna; DAM, Damaturu; MAI, Maiduguri; KAN, Kano; YOL, Yola.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4"><title>Subtype determination</title><p id="Par5">The Nigerian <italic>pol</italic> sequences were aligned with all M group lineages (A-K&#x02009;+&#x02009;Recombinants) of the LANL 2010 Reference Sequence Dataset (<ext-link ext-link-type="uri" xlink:href="http://www.hiv.lanl.gov/">http://www.hiv.lanl.gov/</ext-link>) using the Clustal algorithm, followed by manual editing in MEGA6<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>. The HIV-1 subtype/CRF classification was determined by manual assignment with maximum-likelihood (ML) phylogenetic analysis in Garli v0.98<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> using the General Time Reversible (GTR) substitution model. Branch support was determined in PhyML 3.0 using the approximate likelihood ratio test with the Shimodaira-Hasegawa-like procedure (aLRT-SH)<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. Branches with aLRT-SH support &#x0003e;0.90 were considered statistically supported<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>.</p></sec><sec id="Sec5"><title>Recombination analysis</title><p id="Par6">Putative unique recombinant forms (URFs) and sequences that were difficult to subtype were analysed by Bootscan in Simplot<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Briefly, <italic>pol</italic> sequences were aligned with the LANL 2010 Reference sequences for subtypes for G, CRF4302G and CRF02AG as putative parental sequences. Recombination breakpoints were identified using a sliding window size of 300&#x02009;bp and step size of 50&#x02009;bp. URFs consisting of non-subtype G related forms were excluded from the Simplot analysis.</p><p id="Par7">In order to define the structure and distribution of the breakpoints across the alignment, we plotted a line graph of the relative frequency of the breakpoints. The K-means univariate-clustering algorithm as implemented in the &#x02018;Ckmeans.1d.dp&#x02019; R package was used to define hotspots for recombination<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. The gap statistic method implemented in the &#x02018;factoextra&#x02019; R-package was employed to estimate the groups based on similarity in breakpoint positions obtained from the Simplot analysis<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. The recombination hotspot positions were then used to identify groups of three or more URFs with one or more similar breakpoint positions. Finally, to determine potential new CRFs, we performed a ML phylogenetic analysis using Garli (GTR nucleotide substitution model) to assess the epidemiological relatedness among the sequences<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>.</p></sec><sec id="Sec6"><title>Cluster analysis</title><p id="Par8">A previously described BLAST approach was used to determine non-Nigerian subtype/CRF-specific reference sequences<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. Subtype/CRF-specific reference sequences and Nigerian sequences were aligned and ML phylogenies determined as described previously<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Nigerian transmission clusters were defined as clusters with aLRT-SH support &#x02265;0.90 and composed of &#x02265;80% Nigerian sequences<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>. Clusters of two sequences were defined as dyads, 3&#x02013;14 sequences as networks, and &#x0003e;14 sequences as large clusters<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>.</p></sec><sec id="Sec7"><title>Dated phylogeographic analysis</title><p id="Par9">The temporal signal in each dataset were assessed by estimating the regression between divergence and sampling dates in TempEst<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. For the main Nigerian transmission clusters with little or no temporal structure, we used substitution rate priors obtained by preliminary analysis of 150 randomly selected sequences sampled worldwide for each subtype/CRF. The evolutionary rates were estimated in BEAST v1.8.4<sup><xref ref-type="bibr" rid="CR41">41</xref></sup> using the SRD06 model<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, a relaxed uncorrelated lognormal clock model<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>, and the Bayesian Skygrid coalescent tree prior<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. For each transmission cluster, Markov chain Monte Carlo (MCMC) chains were run for 300 million steps, subsampling parameters and trees every 30000th step. BEAGLE library v.2 was used to improve computational time of likelihood calculations<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Convergence was assessed using Tracer v.1.6. All parameters achieved convergence as determined by effective sample sizes (ESS) &#x02265;100<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>.</p><p id="Par10">We used a Bayesian discrete phylogeographic approach with a MCMC length of 300 million steps in BEAST v1.8.4, sampling every 30000th step, to reconstruct the spatial dynamics of HIV-1 for the identified large clusters<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. Effective population sizes through time was inferred using the Bayesian Skygrid coalescent model<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Growth rates were estimated using the parametric exponential growth rate coalescent model<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup>.</p><p id="Par11">Symmetric and asymmetric continuous time Markov chain models were used to model the location exchange process<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. The most parsimonious description of the location exchange rates was inferred using the Bayesian stochastic search variable selection (BSSVS) procedure<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. A robust counting approach as implemented in BEAST was used to estimate the forward and reverse viral movement events between locations along the branches of time dated phylogenetic trees<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Well-supported movements were summarized using SPREAD v1.0.7 based on a Bayes factors &#x02265;3<sup><xref ref-type="bibr" rid="CR54">54</xref>&#x02013;<xref ref-type="bibr" rid="CR56">56</xref></sup>. The percentage of viral movements between locations was summarized using R<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. All files and scripts are available upon request.</p></sec><sec id="Sec8"><title>Statistics</title><p id="Par12">Linear by linear association test (LBL) was used to analyze trends over time, using IBM SPSS V22.0 Armonk, NY: IBM Corporation.</p></sec><sec id="Sec9"><title>Ethics</title><p id="Par13">All research was performed in accordance with relevant guidelines/regulations, and informed consent was obtained from all participants if appropriate. Specifically, the study utilized secondary data analysis from laboratory database of the National HIV program, which has approval from the Nigerian National Health Research Ethics Committee (NHREC Approval #NHREC/01/01/2007-14/08/2017).</p></sec><sec id="Sec10"><title>Accession numbers for previously unpublished sequences used in this study</title><p id="Par14">The DNA sequences of HIV-1 <italic>pol</italic> PR-RT regions determined as part of this study were submitted to GenBank under the following accession numbers: DQ990400 to DQ990455.</p></sec></sec><sec id="Sec11" sec-type="results"><title>Results</title><sec id="Sec12"><title>CRF02_AG, CRF43_02G and subtype G were the major circulating strains in Nigeria</title><p id="Par15">We analyzed 1442 HIV-1 <italic>pol</italic> sequences collected from four geopolitical zones in Nigeria between 1999 and 2013 (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The phylogenetic analysis showed that the CRF02_AG was the most common strain (44% of the analyzed sequences), followed by CRF43_02G (16%), subtype G (8%) and CRF06_cpx (4%). Three-hundred-and-twenty-eighty of the sequences (23%) were unique recombinant forms (URFs), whereas the remaining sequences were minor variants (each variant accounting for &#x0003c;2%).</p><p id="Par16">Most sequences were from Abuja (697 sequences, 48%), followed by Lagos (346 sequences, 23%) and Jos (216 sequences, 15%). The distribution of different subtypes/CRFs varied within these regions/states with fewer CRF02_AG infections following a North East direction from Lagos (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Analysis of trends over time showed an overall decrease in the proportion of CRF02_AG infections in Nigeria (from 55% in 2006 to 38% in 2013, p&#x02009;=&#x02009;0.015, LBL, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>). Moreover, the analysis also showed an increase in the proportion of unique recombinant forms (URFs) from 16% to 32%, 2005&#x02013;2013 (p&#x02009;=&#x02009;0.015, LBL). The time trend analysis for other CRFs and or subtypes was non-significant.<fig id="Fig1"><label>Figure 1</label><caption><p>Prevalence of subtypes/CRFs among HIV-1 infected individuals collected from different locations in Nigeria. HIV-1 diversity in different zones/regions in Nigeria. The locations of the sampled regions as indicated on the map are connected to their respective diversity pie charts by a dot-headed dashed black line.</p></caption><graphic xlink:href="41598_2020_59944_Fig1_HTML" id="d29e1774"/></fig></p></sec><sec id="Sec13"><title>Four potential recombination hotspots in the <italic>pol</italic> region</title><p id="Par17">Of the 328 identified URFs, 209 constituted variations of the three dominating circulating strains in Nigeria (CRF02_AG, CRF43_02G, and subtype G; Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref>). The remaining 119 URFs consisted of different combinations of various HIV-1 strains less common in Nigeria. We therefore performed a detailed recombination analysis on the 209 URFs consisting of CRF02_AG, CRF43_02G, and subtype G. One-hundred of the 209 URF sequences (48%) were from Abuja; 45 from Lagos (22%); 35 from Jos (17%); 10 from Maiduguri (5%); 9 from Kaduna (4%); seven from Ibadan (3%); and two from Adamawa (1%); and one from Enugu (&#x0003c;1%). These sequences were initially selected from the maximum likelihood phylogenetic trees if they branched off close to the root between two subtypes and had long branches. There were 655 breakpoint positions recorded among the 209 sequences, with some sequences having more than one breakpoint. These positions were plotted as a frequency plot of breakpoints along the alignment to identify hotspots for recombination (i.e. positions in the alignment were recombination breakpoints occur more frequently than the other positions, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>). Alignment positions around 285&#x02013;315 (HXB2 K03455 positions: 2538&#x02013;2568), 503&#x02013;534 (2756&#x02013;2787), 720&#x02013;775 (2973&#x02013;3028) and 923&#x02013;956 (3176&#x02013;3209) were identified as potential recombination hotspots. To define these positions more precisely, we used the inter-quartile range (IQR) of the optimal univariate K-median clustering algorithm with the number of clusters determined by the gap-statistic method (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S3</xref>)<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>: Recombination hotspot I: 294&#x02013;312 (HXB2 K03455 positions: 2547&#x02013;2565); II: 503&#x02013;533 (2756&#x02013;2786); III: 729&#x02013;805 (2982&#x02013;3058); and IV: 931&#x02013;957 (3184&#x02013;3210) (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>). Of the 209 sequences, 139 (67%) had a recombination breakpoint in the hotspot I region; 104 (50%) in hotspot II region; 58 (28%) in hotspot III region; and 59 (28%) in hotspot IV region. The hotspot positions were unique independent recombination events from the original breakpoint positions as previously identified for the parental sequences of CRF43_02G (HXB2 K03455 positions: 1266, 3325, and 6097) and CRF02_AG (HXB2 K03455 positions: 2391, 3275, and 4175). We identified 37 URFs that could be divided into seven groups sharing breakpoint positions (each group consisting of 3&#x02013;10 sequences, respectively, and thereby fulfilling the requirements as potentially novel CRFs; Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>). The majority of these sequences had been collected in Abuja (23/37, 62%).</p></sec><sec id="Sec14"><title>Cluster analysis</title><p id="Par18">To determine transmission clusters of the major circulating strains within Nigeria, we analyzed the three dominating forms: subtype G, CRF02_AG, and CRF43_02G. Analysis of 206 subtype G sequences (119 Nigerian and 87 non-Nigerian) showed four dyads, one network, and one large Nigerian subtype G cluster (consisting of 81 Nigerian and 11 non-Nigerian sequences, Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S5</xref>). The 1161 CRF02_AG sequences (636 Nigerian and 555 non-Nigerian) formed 12 dyads, 12 networks and six clusters (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S6</xref>). Finally, analysis of the 295 CRF43_02G sequences (236 Nigerian and 59 non-Nigerian) showed that all the Nigerian sequences clustered monophyletically (SH-aLRT&#x02009;=&#x02009;0.99, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7</xref>), suggesting that CRF43_02G predominately circulates in Nigeria.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Number of clusters in the different subtype/CRF groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Subtype/CRF</th><th>Dyads<sup>a</sup></th><th>Networks<sup>b</sup></th><th>Large clusters<sup>c</sup></th><th>Total</th></tr></thead><tbody><tr><td>G</td><td>8 (4)</td><td>8 (2)</td><td>94 (1)</td><td>104</td></tr><tr><td>CRF02_AG</td><td>24 (12)</td><td>76 (12)</td><td>336 (6)</td><td>439</td></tr><tr><td>CRF43_02G</td><td>0 (0)</td><td>0 (0)</td><td>295 (1)</td><td>295</td></tr><tr><td><bold>Total</bold></td><td><bold>32</bold></td><td><bold>84</bold></td><td><bold>725</bold></td><td><bold>841</bold></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Dyads: Clusters of 2 sequences.</p><p><sup>b</sup>Networks: Clusters of 3&#x02013;14 sequences.</p><p><sup>c</sup>Large clusters: Clusters with more than 14 sequences.</p><p>The number of clusters observed for the different groups are indicated in brackets.</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec15"><title>Dates of origin and evolutionary rates of the main Nigerian transmission clusters</title><p id="Par19">To further dissect the Nigerian HIV-1 epidemic, we performed a detailed analysis of the five largest Nigerian clusters (one subtype G, three CRF02_AG, and one CRF43_02G). The time to most recent common ancestor (tMRCA) of the Nigerian subtype G cluster was 1975 (95%HPD: 1969&#x02013;1982). The corresponding estimates for the CRF02_AG clusters were 1963 (95%HPD: 1948&#x02013;1974), 1970 (95%HPD: 1960&#x02013;1980) and 1960 (95%HPD: 1947&#x02013;1974) for cluster 1, 2 and 3, respectively; and 1971 (95%HPD: 1952&#x02013;1983) for the CRF43_02G cluster (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8</xref>). The HIV-1 evolutionary rate for the Nigerian subtype G cluster was 2.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> substitutions/site/year (s/s/y, 95%HPD:&#x02009;1.67&#x02013;2.53&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>&#x02009;s/s/y). The rates for the CRF02_AG clusters 1, 2 and 3 was slightly lower: 1.42&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> s/s/y (95% HPD:&#x02009;1.07&#x02013;1.85&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>&#x02009;s/s/y) for cluster 1; 1.34&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> s/s/y (95%HPD:&#x02009;1.02&#x02013;1.72&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>&#x02009;s/s/y) for cluster 2; and 1.22&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> s/s/y (95%HPD:&#x02009;0.91&#x02013;1.57&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>&#x02009;s/s/y) for cluster 3. Finally, the rate for the CRF43_02G cluster was estimated to 2.72&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> s/s/y (95%HPD:&#x02009;1.59&#x02013;3.73&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>&#x02009;s/s/y) (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8</xref>).</p><p id="Par20">To assess the impact of sampling bias in our phylogeographic inference, we conducted a control analysis of the effects of potential over-representations of samples from particular regions in Nigeria (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Sequences were randomly selected based on population growth over time and HIV-1 prevalence in the different geographic regions. Information on the&#x000a0;Nigerian population growth over time&#x000a0;was obtained from&#x000a0;the National Population Commission of Nigeria/National Bureau of Statistics for the population census, and information on HIV-1 prevalence was obtained from National Agency for the Control of AIDS<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. In these analyses, the median tMRCA of the Nigerian subtype G cluster was estimated to 1987 (95%HPD: 1982&#x02013;1992); and the CRF02_AG clusters to 1974 (95%HPD: 1960&#x02013;1983), 1972 (95%HPD: 1973&#x02013;1981), 1961 (95%HPD: 1952&#x02013;1979) for cluster 1, 2 and 3, respectively. Despite numerous attempts, the CRF43_02G control analysis did not reach sufficient temporal signal to converge.</p></sec><sec id="Sec16"><title>Disentangling the demographic history of the main Nigerian transmission clusters</title><p id="Par21">The analysis of the Nigerian subtype G epidemic showed that the number of effective infections, a proxy of HIV incidence, underwent a fast exponential growth between the 1970s and the mid-1990s, followed by a marginal decrease with minor fluctuations from the mid-1990s and onwards (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>)<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Using the exponential growth model, the median growth rate was 0.3 per year (95%HPD: 0.18&#x02013;0.42). The three clusters representing the CRF02_AG epidemic displayed a similar pattern with a slow increase in growth rate from the 1980s to 2000s. The median CRF02_AG growth rates were estimated to 0.22 per year (95%HPD: 0.13&#x02013;0.32) for cluster 1; 0.18 per year (95%HPD: 0.10&#x02013;0.26) for cluster 2; and 0.24 (95%HPD: 0.11&#x02013;0.38) for cluster 3 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Finally, the CRF43_02G cluster had a median growth rate of 0.39 per year (95%HPD: 0.23&#x02013;0.55). The CRF43_02G cluster had low temporal signal that could not inform the complex non-parametric coalescent model and thus only an exponential model was used to capture the demographic dynamics (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig2"><label>Figure 2</label><caption><p>Skygrid plots for the different clusters. Phylodynamic analyses of HIV-1 <italic>pol</italic> gene for subtype G and CRF02_AG isolated in Nigeria. Bayesian Skygrid plots representing the changes in the effective population size of the virus (<italic>N</italic><sub><italic>e</italic></sub>) over time. The solid lines represent the estimated median log effective population size and the colour-coded shaded areas represent the 95%HPD intervals for the different clusters circulating in Nigeria. The gray-shaded area starts at the period when ART was introduced in Nigeria.</p></caption><graphic xlink:href="41598_2020_59944_Fig2_HTML" id="d29e2028"/></fig><fig id="Fig3"><label>Figure 3</label><caption><p>Estimated percentages of viral migration events from Abuja to each location in Nigeria. The density plot for the viral movements from the Abuja (most probable root location) to Lagos, Jos, Kaduna and other towns. Lagos had the highest percentage of viral movements from Abuja for the CRF02_AG cluster 1, and CRF02_AG cluster 3; whereas Jos had the highest percentage of viral movements from Abuja for CRF02_AG cluster 2 and subtype G.</p></caption><graphic xlink:href="41598_2020_59944_Fig3_HTML" id="d29e2037"/></fig></p></sec><sec id="Sec17"><title>Phylogeographic dispersal of HIV-1 in the main Nigerian subepidemics</title><p id="Par22">Next, we sought to investigate the spatiotemporal spread of HIV-1 in Nigeria using both asymmetric and symmetric discrete phylogeographic diffusion models. From the asymmetric analysis, various sample locations (cities) had well supported exchange rates that dominated the diffusion process of the different subepidemics. For subtype G, significant transition between Lagos and Ibadan (Bayes Factor [BF]&#x02009;=&#x02009;241), Damaturu (BF&#x02009;=&#x02009;109), Minna (BF&#x02009;=&#x02009;174), and Jos (BF&#x02009;=&#x02009;98) were identified. Frequently invoked rates were also identified between Abuja and Lagos (BF&#x02009;=&#x02009;81), Kaduna (BF&#x02009;=&#x02009;220), Ibadan (BF&#x02009;=&#x02009;223), Damaturu (BF&#x02009;=&#x02009;293) and Minna (BF&#x02009;=&#x02009;138). Supported rates from Kaduna, Jos and Ibadan to the other locations within Nigeria were also found. Finally, the analysis also indicated significant international linkages to and from Lagos (BF&#x02009;=&#x02009;74), Abuja (BF&#x02009;=&#x02009;80), Kaduna (BF&#x02009;=&#x02009;21), Jos (BF&#x02009;=&#x02009;501), Damaturu (BF&#x02009;=&#x02009;80), and Ibadan (BF&#x02009;=&#x02009;207). The symmetric models gave similar results as the asymmetric model.</p><p id="Par23">For the CRF02_AG cluster 1, Abuja was connected to Ibadan (BF&#x02009;=&#x02009;105), Kaduna (BF&#x02009;=&#x02009;687), and Jos (BF&#x02009;=&#x02009;116); Lagos was connected to Ibadan (BF&#x02009;=&#x02009;512), Kaduna (BF&#x02009;=&#x02009;134) and Oyo (BF&#x02009;=&#x02009;139); Kaduna was connected to Jos (BF&#x02009;=&#x02009;207), Ibadan (BF&#x02009;=&#x02009;371) and Oyo (BF&#x02009;&#x0003e;&#x02009;1000). International linkage was also found for Lagos (BF&#x02009;=&#x02009;639), Abuja (BF&#x02009;=&#x02009;184), Ibadan (BF&#x02009;=&#x02009;462) and Oyo (BF&#x02009;=&#x02009;275). For CRF02_AG cluster 2, Lagos was connected to Jos (BF&#x02009;=&#x02009;395), Maiduguri (BF&#x02009;=&#x02009;231), Ibadan (BF&#x02009;&#x0003e;&#x02009;1000) and Kaduna (BF&#x02009;=&#x02009;383); Abuja to Kaduna (BF&#x02009;=&#x02009;155), Ibadan (BF&#x02009;=&#x02009;110), Kano (BF&#x02009;=&#x02009;543) and Oyo (BF&#x02009;=&#x02009;58); and Ibadan to Kaduna, Jos, Oyo, Kano, and Maiduguri. For the CRF02_AG cluster 3, Lagos was connected to Abuja (BF&#x02009;=&#x02009;118), Jos (BF&#x02009;=&#x02009;87) and Maiduguri (BF&#x02009;=&#x02009;56). Abuja was connected to Ibadan (BF&#x02009;=&#x02009;45), Jos (BF&#x02009;=&#x02009;44) and Maiduguri (BF&#x02009;=&#x02009;29).</p><p id="Par24">As described above, the CRF43_02G cluster had low temporal signal and could not inform the complex phylogeographic analysis. Finally, based on posterior probability support, the location of the spatial origin of subtype G, and CRF02_AG clusters was Abuja (posterior probability&#x02009;&#x02265;&#x02009;0.98).</p></sec><sec id="Sec18"><title>Rates of viral lineage migration</title><p id="Par25">The rates of viral lineage migration within Nigeria were estimated using a robust counting approach. For subtype G, 42% (95%HPD: 35&#x02013;48%) of all virus migrations originated in Abuja; of these 17% (95%HPD: 12&#x02013;22%) were directed to Jos, 10% (95%HPD: 8&#x02013;13%) to outside Nigeria, and 7% (95%HPD: 4&#x02013;10%) to Lagos. Similar results were found for the CRF02_AG clusters, except for slightly higher migration rates from Abuja to Lagos for cluster 1 (30%, 95%HPD: 25&#x02013;34%, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Overall, the CRF02_AG migration rates originating in Abuja was 61%, 52% and 21% for cluster 1, 2 and 3, respectively.</p></sec></sec><sec id="Sec19" sec-type="discussion"><title>Discussion</title><p id="Par26">In this study, we aimed to disentangle the history and spread of HIV-1 subtypes/CRFs in Nigeria using state-of-the-art phylogenetics to a large set of HIV-1 sequences collected in the five most populated Nigerian geopolitical zones. To the best of our knowledge, only one previous nationwide molecular epidemiology study from Nigeria have been presented<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. In this study, 55 HIV-1 <italic>gp41</italic> sequences (approximately 400&#x02009;bp) collected throughout Nigeria during 1999 were analysed by neighbour-joining phylogenetics. However, the analysis was unable to distinguish between subtype A and CRF02_AG sequences &#x02013; likely due to insufficient phylogenetic information in&#x000a0;this relatively short gene fragment, as suggested by&#x000a0;the authors. In-depth phylogenetic and phylodynamic analysis was therefore not possible in this study. In comparison, we analysed 1442 HIV-1 <italic>pol</italic> sequences (approximately 1000&#x02009;bp long) collected throughout Nigeria between 1999 and 2013 using maximum-likelihood and Bayesian phylogenetics. Importantly, the HIV-1 <italic>pol</italic> gene (which is the most targeted genetic region for HIV-1 sequencing and by far most commonly analysed region in studies of HIV-1 molecular epidemiology) holds sufficient intrinsic genetic variability to permit the reconstruction of transmission histories by phylogenetic approaches<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR61">61</xref></sup>. Hence, the larger size of our dataset, the relatively long time-window of sampling, and the use of state-of-the-art phylodynamic methods enabled us to perform the first in-depth nationwide HIV-1 phylodynamic study in Nigeria. In line with other previous studies from different geographic regions in Nigeria, we found that CRF02_AG, CRF43_02G and subtype G were the most prevalent strains (previous estimates ranging from 19&#x02013;60% for CRF02_AG and 22&#x02013;50% for subtype G<sup><xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>). The prevalence of CRF43_02G has only been reported in one previous study from Abuja (estimated to 19%)<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. Non-representative sampling or local fluctuations between geographic regions in Nigeria could explain the large variations and discrepancies between studies. It could also be explained, in part, by the use of different subtyping tools between studies (which can differ in accuracy in assigning the correct subtype/CRF based on partial genome sequences)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p><p id="Par27">We found one large well-supported monophyletic cluster for both subtype G and CRF43_02G, respectively. Each of these clusters harbored the majority of Nigerian sequences, suggesting single strain introductions that grew out to dominate the Nigerian HIV-1 epidemic. Previous studies have used different nomenclatures of subtype G. A comparison of accession numbers showed that our subtype G cluster is partly consistent with the subtype G&#x02019; cluster identified by Chaplin <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Further dissection of the subtype G&#x02019; cluster showed that approximately half of the sequences belonged to subtype G, whereas the other half clustered with the CRF43_02G sequences in our analysis. In a more recent study, Delatorre <italic>et al</italic>. suggested a nomenclature based on geographic dissemination<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. The clustering pattern of the West African strain defined as subtype G<sub>WA-II</sub> was largely overlapping with the Nigerian subtype G cluster in our analysis<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. We estimated the date of origin for the subtype G cluster to 1975 (95%HPD: 1969&#x02013;1982), which is consistent with the origin of the subtype G<sub>WA-II</sub> cluster that was estimated to 1979 [95%HPD: 1973&#x02013;1984])<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. In addition, the estimated date of origin also fits with the fact that the first AIDS cases were identified in Nigeria in 1986, approximately one decade after the introduction of this virus strain<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>. The CRF43_02G was first described and isolated in Saudi Arabia in 2008<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Interestingly, the G<sub>WA-I</sub> cluster determined by Delatorre <italic>et al</italic>. consisted of 140/168 (83%) sequences from Nigeria<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. In our analysis, more than half of the G<sub>WA-I</sub> sequences clustered with the CRF43_02G strain. Spatiotemporal analysis of the G<sub>WA-I</sub> cluster indicated that this strain emerged in Nigeria in the mid-1970&#x02019;s<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. This is consistent with our estimate of 1971 (95%HPD: 1952&#x02013;1983) for the CRF43_02G cluster. Moreover, the majority of CRF43_02G sequences in Genbank are of Nigerian origin (<ext-link ext-link-type="uri" xlink:href="http://www.hiv.lanl.gov">www.hiv.lanl.gov</ext-link>), and both the putative parental strains of CRF43_02G in Nigeria (CRF02_AG and subtype G) are highly prevalent. Altogether, this suggests that CRF43_02G originated in central West Africa, in or close to Nigeria.</p><p id="Par28">In contrast to subtype G and CRF43_02G, where only one of the respective introductions resulted in major subepidemics, three large Nigerian subepidemics were found for CRF02_AG. The underlying mechanisms for this strain-specific difference are unknown. However, the CRF02_AG strain is the most prevalent strain in West Africa, and a previous study of the West Central African CRF02_AG epidemic estimated that this strain originated in the Democratic Republic of the Congo (DRC) in 1973 (95%HPD: 1972&#x02013;1975)<sup><xref ref-type="bibr" rid="CR65">65</xref></sup>. This is in line with a previous study by Abecasis <italic>et al</italic>. that estimated the CRF02_AG date of origin to 1976 (95%HPD: 1971&#x02013;1981)<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>. However, a more detailed analysis of the CRF02_AG strain by Mir <italic>et al</italic>. indicated that seven subvariants of CRF02_AG are circulating (as determined by a combination of phylogenetics and geographic dissemination)<sup><xref ref-type="bibr" rid="CR67">67</xref></sup>. The seven subvariants of CRF02_AG were estimated to have originated between 1967 and 2003 (combined 95%HPD: 1961&#x02013;2005). More specifically, the analysis indicated that the oldest strain was the West African CRF02_AG strain (introduced 1967 [95%HPD: 1961&#x02013;1974]). The three CRF02_AG clusters identified in the current study were estimated to have originated between 1963 and 1970 (combined 95%HPD: 1948&#x02013;1980). Although the 95%HPD intervals are overlapping with the estimates suggesting the origin to be the DRC, they are on the lower side. Moreover, the CRF02_AG strain was first isolated in Nigeria in 1996<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. Due to the somewhat conflicting data presented above, further analysis is needed to provide solid evidence of the geographical origin of the CRF02_AG strain.</p><p id="Par29">Bayesian demographic analysis indicated an increase in the number of effective infections 1970&#x02013;1995 in all the analysed clusters. Interestingly, a rapid population growth occurred in Nigeria during the same period (from 56 to 108 million people, <ext-link ext-link-type="uri" xlink:href="http://www.worldometers.info/world-population/nigeria-population">www.worldometers.info/world-population/nigeria-population</ext-link>). This increase was followed by a decline in number of effective infections that coincided with the introduction of free ART in Nigeria in 2006, which resulted in a decrease in HIV-1 prevalence from 6% to 3% in Nigeria the following years<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>. Moreover, our analysis suggested that urban areas like Abuja and Lagos were the major hubs of HIV-1 transmission in Nigeria. This is in line with previous reports from West Africa<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. However, it should be noted that the majority of the sequences were collected in Abuja, and potential transmissions from other cities may therefore not have been captured in our analysis.</p><p id="Par30">The recombination analysis indicated several URFs and potentially novel CRFs. Recombination does not occur randomly on the HIV-1 genome as its frequency varies along its length with several so-called hotspots for recombination<sup><xref ref-type="bibr" rid="CR70">70</xref>,<xref ref-type="bibr" rid="CR71">71</xref></sup>. One main hotspot for recombination (found in 105 sequences) was close to the <italic>pol PR-RT</italic> border (positions 2547&#x02013;2565 in the HIV-1 HXB2 reference genome, K03455). This hotspot has previously been reported in a study on HIV-1 subtype B<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. The hotspot positions II and IV have also been reported previously<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. To date, eighteen distinct subtype G-related CRFs have been described (<ext-link ext-link-type="uri" xlink:href="http://www.hiv.lanl.gov">www.hiv.lanl.gov</ext-link>). We identified seven groups of URFs with similar recombination breakpoint patterns. These could represent novel CRFs or second-generation recombinants circulating in Nigeria. However, full-length genome sequencing is needed to confirm whether these groups represent similar URFs or previously unknown subtype G-related CRFs.</p><p id="Par31">In summary, this is the first in-depth HIV-1 phylodynamic study based on a nationwide set of HIV-1 sequences from Nigeria. We found a high number of URFs and potential new CRFs, and our analyses suggested that HIV-1 first emerged and expanded within large urban centers before migrating to smaller rural areas. The number of effective infections declined in the early 2000s, coinciding with the introduction of free ART in Nigeria. This study increases our understanding of the Nigerian HIV-1 epidemic and may inform HIV-1 intervention strategies to reduce the spread of HIV-1 in Nigeria.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec20"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2020_59944_MOESM1_ESM.pdf"><caption><p>Supplementary Information.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p>is available for this paper at 10.1038/s41598-020-59944-x.</p></sec><ack><title>Acknowledgements</title><p>We thank all the study participants, the collaborating health centers in Nigeria, Federal Ministry of Health and the National Agency for the Control of AIDS (NACA) in Nigeria. The study was supported by the Swedish Research Council (No. 350-2012-6628 and 2016-01417), Swedish Society of Medical Research (SA-2016), the Medical Faculty at Lund University, the US NIH R01 AI147331-01 (RAI147331A), and the US Centers for Disease Control and Prevention to the Institute of Human Virology Nigeria (5U2GGH000925). Open access funding provided by Lund University.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>J.N., N.N. and J.E. interpreted the data and were responsible for the overall study design. N.N. and J.E. were responsible for the overall project coordination. H.R., B.C., N.N., P.K., P.D., A.A., M.C. were medically and organizationally responsible for the clinical sites and collected key epidemiological data of the study participants. J.N., N.R.F., N.N. and J.E. analyzed the data and contributed in statistical analyses. J.N. and J.E. wrote the manuscript. All authors read and approved the manuscript.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par32">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottlieb</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency</article-title><source>The New England journal of medicine</source><year>1981</year><volume>305</volume><fpage>1425</fpage><lpage>1431</lpage><pub-id pub-id-type="doi">10.1056/NEJM198112103052401</pub-id><?supplied-pmid 6272109?><pub-id pub-id-type="pmid">6272109</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">UNAIDS. UNAIDS, Global Reports - UNAIDS report on the global AIDS epidemic 2016. (2017).</mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palm</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3/CRF02_AG compared with sub-subtype A3</article-title><source>The Journal of infectious diseases</source><year>2014</year><volume>209</volume><fpage>721</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1093/infdis/jit416</pub-id><?supplied-pmid 23935204?><pub-id pub-id-type="pmid">23935204</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Naidoo, V. L. <italic>et al</italic>. Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity. <italic>Journal of virology</italic><bold>91</bold>(2017).</mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Laher, F. <italic>et al</italic>. HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer(+) Gag-Specific CD4(+) T Cells in Chronic Clade C HIV-1 Infection. <italic>Journal of virology</italic><bold>91</bold> (2017).</mixed-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiwanuka</surname><given-names>N</given-names></name><etal/></person-group><article-title>HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda</article-title><source>J Acquir Immune Defic Syndr</source><year>2010</year><volume>54</volume><fpage>180</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1097/QAI.0b013e3181c98fc0</pub-id><?supplied-pmid 20010433?><pub-id pub-id-type="pmid">20010433</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baeten</surname><given-names>JM</given-names></name><etal/></person-group><article-title>HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads</article-title><source>The Journal of infectious diseases</source><year>2007</year><volume>195</volume><fpage>1177</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1086/512682</pub-id><?supplied-pmid 17357054?><pub-id pub-id-type="pmid">17357054</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senkaali</surname><given-names>D</given-names></name><etal/></person-group><article-title>The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort</article-title><source>AIDS Res Hum Retroviruses</source><year>2004</year><volume>20</volume><fpage>932</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1089/aid.2004.20.932</pub-id><?supplied-pmid 15585080?><pub-id pub-id-type="pmid">15585080</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaleebu</surname><given-names>P</given-names></name><etal/></person-group><article-title>Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort</article-title><source>AIDS</source><year>2001</year><volume>15</volume><fpage>293</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1097/00002030-200102160-00001</pub-id><?supplied-pmid 11273208?><pub-id pub-id-type="pmid">11273208</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanki</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Human immunodeficiency virus type 1 subtypes differ in disease progression</article-title><source>The Journal of infectious diseases</source><year>1999</year><volume>179</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1086/314557</pub-id><?supplied-pmid 9841824?><pub-id pub-id-type="pmid">9841824</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esbjornsson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease&#x02013;indication of an evolving epidemic in West Africa</article-title><source>Retrovirology</source><year>2010</year><volume>7</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.1186/1742-4690-7-23</pub-id><?supplied-pmid 20307309?><pub-id pub-id-type="pmid">20307309</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mild</surname><given-names>M</given-names></name><etal/></person-group><article-title>High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch</article-title><source>Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases</source><year>2013</year><volume>19</volume><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2013.05.004</pub-id><?supplied-pmid 23672855?><pub-id pub-id-type="pmid">23672855</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laga</surname><given-names>M</given-names></name></person-group><article-title>Effect of HIV prevention in key populations: evidence accumulates, time to implement</article-title><source>Lancet Glob Health</source><year>2013</year><volume>1</volume><fpage>e243</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(13)70096-2</pub-id><?supplied-pmid 25104483?><pub-id pub-id-type="pmid">25104483</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granich</surname><given-names>R</given-names></name><etal/></person-group><article-title>Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990&#x02013;2013</article-title><source>PloS one</source><year>2015</year><volume>10</volume><fpage>e0131353</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0131353</pub-id><?supplied-pmid 26147987?><pub-id pub-id-type="pmid">26147987</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">UNAIDS. UNAIDS DATA 2018. (2018).</mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">(NACA), N.A.F.T.C.O.A. Global AIDS Response Country Progress report Nigeria GARPR 2015. (2015).</mixed-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajoge</surname><given-names>HO</given-names></name><etal/></person-group><article-title>Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in North-Central Nigeria</article-title><source>AIDS Res Hum Retroviruses</source><year>2012</year><volume>28</volume><fpage>115</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1089/aid.2011.0115</pub-id><?supplied-pmid 21568761?><pub-id pub-id-type="pmid">21568761</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imade</surname><given-names>GE</given-names></name><etal/></person-group><article-title>Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria</article-title><source>AIDS Res Hum Retroviruses</source><year>2014</year><volume>30</volume><fpage>127</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1089/aid.2013.0074</pub-id><?supplied-pmid 24164431?><pub-id pub-id-type="pmid">24164431</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volz</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics</article-title><source>Virus evolution</source><year>2017</year><volume>3</volume><fpage>vex014</fpage><?supplied-pmid 28775893?><pub-id pub-id-type="pmid">28775893</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charurat</surname><given-names>M</given-names></name><etal/></person-group><article-title>Characterization of acute HIV-1 infection in high-risk Nigerian populations</article-title><source>The Journal of infectious diseases</source><year>2012</year><volume>205</volume><fpage>1239</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis103</pub-id><?supplied-pmid 22357663?><pub-id pub-id-type="pmid">22357663</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diallo</surname><given-names>K</given-names></name><name><surname>Zheng</surname><given-names>DP</given-names></name><name><surname>Rottinghaus</surname><given-names>EK</given-names></name><name><surname>Bassey</surname><given-names>O</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name></person-group><article-title>Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria</article-title><source>AIDS Res Hum Retroviruses</source><year>2015</year><volume>31</volume><fpage>564</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1089/aid.2014.0168</pub-id><?supplied-pmid 25582324?><pub-id pub-id-type="pmid">25582324</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaplin</surname><given-names>B</given-names></name><etal/></person-group><article-title>Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy</article-title><source>AIDS Res Hum Retroviruses</source><year>2011</year><volume>27</volume><fpage>71</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1089/aid.2010.0050</pub-id><?supplied-pmid 20964479?><pub-id pub-id-type="pmid">20964479</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojesina</surname><given-names>AI</given-names></name><etal/></person-group><article-title>Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response</article-title><source>AIDS Res Hum Retroviruses</source><year>2006</year><volume>22</volume><fpage>770</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1089/aid.2006.22.770</pub-id><?supplied-pmid 16910833?><pub-id pub-id-type="pmid">16910833</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajoge</surname><given-names>HO</given-names></name><etal/></person-group><article-title>Genetic characteristics, coreceptor usage potential and evolution of Nigerian HIV-1 subtype G and CRF02_AG isolates</article-title><source>PloS one</source><year>2011</year><volume>6</volume><fpage>e17865</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0017865</pub-id><?supplied-pmid 21423811?><pub-id pub-id-type="pmid">21423811</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamers</surname><given-names>RL</given-names></name><etal/></person-group><article-title>HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study</article-title><source>The Lancet. Infectious diseases</source><year>2011</year><volume>11</volume><fpage>750</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(11)70149-9</pub-id><?supplied-pmid 21802367?><pub-id pub-id-type="pmid">21802367</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>AS</given-names></name><name><surname>Pybus</surname><given-names>OG</given-names></name><name><surname>Sanders</surname><given-names>EJ</given-names></name><name><surname>Albert</surname><given-names>J</given-names></name><name><surname>Esbjornsson</surname><given-names>J</given-names></name></person-group><article-title>Defining HIV-1 transmission clusters based on sequence data</article-title><source>Aids</source><year>2017</year><volume>31</volume><fpage>1211</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000001470</pub-id><?supplied-pmid 28353537?><pub-id pub-id-type="pmid">28353537</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pineda-Pena</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools</article-title><source>Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases</source><year>2013</year><volume>19</volume><fpage>337</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2013.04.032</pub-id><?supplied-pmid 23660484?><pub-id pub-id-type="pmid">23660484</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkin</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Clustal W and Clustal X version 2.0</article-title><source>Bioinformatics (Oxford, England)</source><year>2007</year><volume>23</volume><fpage>2947</fpage><lpage>2948</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btm404</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>K</given-names></name><name><surname>Stecher</surname><given-names>G</given-names></name><name><surname>Peterson</surname><given-names>D</given-names></name><name><surname>Filipski</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>MEGA6: Molecular Evolutionary Genetics Analysis version 6.0</article-title><source>Molecular biology and evolution</source><year>2013</year><volume>30</volume><fpage>2725</fpage><lpage>2729</lpage><pub-id pub-id-type="doi">10.1093/molbev/mst197</pub-id><?supplied-pmid 3840312?><pub-id pub-id-type="pmid">24132122</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Zwickl, D. J. Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion. <italic>PhD thesis</italic> (2006).</mixed-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guindon</surname><given-names>S</given-names></name><etal/></person-group><article-title>New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0</article-title><source>Systematic biology</source><year>2010</year><volume>59</volume><fpage>307</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1093/sysbio/syq010</pub-id><?supplied-pmid 20525638?><pub-id pub-id-type="pmid">20525638</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esbjornsson</surname><given-names>J</given-names></name><etal/></person-group><article-title>HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries</article-title><source>Virus evolution</source><year>2016</year><volume>2</volume><fpage>vew010</fpage><pub-id pub-id-type="doi">10.1093/ve/vew010</pub-id><?supplied-pmid 27774303?><pub-id pub-id-type="pmid">27774303</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lole</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination</article-title><source>Journal of virology</source><year>1999</year><volume>73</volume><fpage>152</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1128/JVI.73.1.152-160.1999</pub-id><?supplied-pmid 9847317?><pub-id pub-id-type="pmid">9847317</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>M</given-names></name></person-group><article-title>Ckmeans.1d.dp: Optimal k-means Clustering in One Dimension by Dynamic Programming</article-title><source>The R journal</source><year>2011</year><volume>3</volume><fpage>29</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.32614/RJ-2011-015</pub-id><?supplied-pmid 27942416?><pub-id pub-id-type="pmid">27942416</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Kassambara, A. factoextra: Extract and Visualize the Results of Multivariate Data Analyses. (2017).</mixed-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>DL</given-names></name><etal/></person-group><article-title>HIV-1 Nomenclature Proposal</article-title><source>Science</source><year>2000</year><volume>288</volume><fpage>55</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1126/science.288.5463.55d</pub-id><?supplied-pmid 10766634?><pub-id pub-id-type="pmid">10766634</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Gish</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name></person-group><article-title>Basic local alignment search tool</article-title><source>Journal of molecular biology</source><year>1990</year><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><?supplied-pmid 2231712?><pub-id pub-id-type="pmid">2231712</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anisimova</surname><given-names>M</given-names></name><name><surname>Gil</surname><given-names>M</given-names></name><name><surname>Dufayard</surname><given-names>JF</given-names></name><name><surname>Dessimoz</surname><given-names>C</given-names></name><name><surname>Gascuel</surname><given-names>O</given-names></name></person-group><article-title>Survey of branch support methods demonstrates accuracy, power, and robustness of fast likelihood-based approximation schemes</article-title><source>Systematic biology</source><year>2011</year><volume>60</volume><fpage>685</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1093/sysbio/syr041</pub-id><?supplied-pmid 21540409?><pub-id pub-id-type="pmid">21540409</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldous</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Characterizing HIV transmission networks across the United States</article-title><source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source><year>2012</year><volume>55</volume><fpage>1135</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1093/cid/cis612</pub-id><pub-id pub-id-type="pmid">22784872</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rambaut</surname><given-names>A</given-names></name><name><surname>Lam</surname><given-names>TT</given-names></name><name><surname>Max Carvalho</surname><given-names>L</given-names></name><name><surname>Pybus</surname><given-names>OG</given-names></name></person-group><article-title>Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen)</article-title><source>Virus evolution</source><year>2016</year><volume>2</volume><fpage>vew007</fpage><lpage>vew007</lpage><pub-id pub-id-type="doi">10.1093/ve/vew007</pub-id><?supplied-pmid 27774300?><pub-id pub-id-type="pmid">27774300</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>AJ</given-names></name><name><surname>Suchard</surname><given-names>MA</given-names></name><name><surname>Xie</surname><given-names>D</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name></person-group><article-title>Bayesian phylogenetics with BEAUti and the BEAST 1.7</article-title><source>Molecular biology and evolution</source><year>2012</year><volume>29</volume><fpage>1969</fpage><lpage>1973</lpage><pub-id pub-id-type="doi">10.1093/molbev/mss075</pub-id><?supplied-pmid 22367748?><pub-id pub-id-type="pmid">22367748</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>B</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name><name><surname>Drummond</surname><given-names>AJ</given-names></name></person-group><article-title>Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences</article-title><source>Molecular biology and evolution</source><year>2006</year><volume>23</volume><fpage>7</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1093/molbev/msj021</pub-id><?supplied-pmid 16177232?><pub-id pub-id-type="pmid">16177232</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishino</surname><given-names>H</given-names></name><name><surname>Thorne</surname><given-names>JL</given-names></name><name><surname>Bruno</surname><given-names>WJ</given-names></name></person-group><article-title>Performance of a divergence time estimation method under a probabilistic model of rate evolution</article-title><source>Molecular biology and evolution</source><year>2001</year><volume>18</volume><fpage>352</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a003811</pub-id><?supplied-pmid 11230536?><pub-id pub-id-type="pmid">11230536</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorne</surname><given-names>JL</given-names></name><name><surname>Kishino</surname><given-names>H</given-names></name><name><surname>Painter</surname><given-names>IS</given-names></name></person-group><article-title>Estimating the rate of evolution of the rate of molecular evolution</article-title><source>Molecular biology and evolution</source><year>1998</year><volume>15</volume><fpage>1647</fpage><lpage>1657</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a025892</pub-id><?supplied-pmid 9866200?><pub-id pub-id-type="pmid">9866200</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>AJ</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name><name><surname>Shapiro</surname><given-names>B</given-names></name><name><surname>Pybus</surname><given-names>OG</given-names></name></person-group><article-title>Bayesian coalescent inference of past population dynamics from molecular sequences</article-title><source>Molecular biology and evolution</source><year>2005</year><volume>22</volume><fpage>1185</fpage><lpage>1192</lpage><pub-id pub-id-type="doi">10.1093/molbev/msi103</pub-id><?supplied-pmid 15703244?><pub-id pub-id-type="pmid">15703244</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayres</surname><given-names>DL</given-names></name><etal/></person-group><article-title>BEAGLE: an application programming interface and high-performance computing library for statistical phylogenetics</article-title><source>Systematic biology</source><year>2012</year><volume>61</volume><fpage>170</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1093/sysbio/syr100</pub-id><?supplied-pmid 21963610?><pub-id pub-id-type="pmid">21963610</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="other">Rambaut, A., Suchard, M. A., Xie, D. &#x00026; Drummond, A. J. Tracer v1.6, Available from <ext-link ext-link-type="uri" xlink:href="http://tree.bio.ed.ac.uk/software/tracer/">http://tree.bio.ed.ac.uk/software/tracer/</ext-link>. (2014).</mixed-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemey</surname><given-names>P</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name><name><surname>Welch</surname><given-names>JJ</given-names></name><name><surname>Suchard</surname><given-names>MA</given-names></name></person-group><article-title>Phylogeography takes a relaxed random walk in continuous space and time</article-title><source>Molecular biology and evolution</source><year>2010</year><volume>27</volume><fpage>1877</fpage><lpage>1885</lpage><pub-id pub-id-type="doi">10.1093/molbev/msq067</pub-id><?supplied-pmid 20203288?><pub-id pub-id-type="pmid">20203288</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baele</surname><given-names>G</given-names></name><etal/></person-group><article-title>Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty</article-title><source>Molecular biology and evolution</source><year>2012</year><volume>29</volume><fpage>2157</fpage><lpage>2167</lpage><pub-id pub-id-type="doi">10.1093/molbev/mss084</pub-id><?supplied-pmid 22403239?><pub-id pub-id-type="pmid">22403239</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>AR</given-names></name><name><surname>Harpending</surname><given-names>H</given-names></name></person-group><article-title>Population growth makes waves in the distribution of pairwise genetic differences</article-title><source>Molecular biology and evolution</source><year>1992</year><volume>9</volume><fpage>552</fpage><lpage>569</lpage><?supplied-pmid 1316531?><pub-id pub-id-type="pmid">1316531</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slatkin</surname><given-names>M</given-names></name><name><surname>Hudson</surname><given-names>RR</given-names></name></person-group><article-title>Pairwise comparisons of mitochondrial DNA sequences in stable and exponentially growing populations</article-title><source>Genetics</source><year>1991</year><volume>129</volume><fpage>555</fpage><lpage>562</lpage><?supplied-pmid 1743491?><pub-id pub-id-type="pmid">1743491</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemey</surname><given-names>P</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name><name><surname>Drummond</surname><given-names>AJ</given-names></name><name><surname>Suchard</surname><given-names>MA</given-names></name></person-group><article-title>Bayesian phylogeography finds its roots</article-title><source>PLoS computational biology</source><year>2009</year><volume>5</volume><fpage>e1000520</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1000520</pub-id><?supplied-pmid 19779555?><pub-id pub-id-type="pmid">19779555</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minin</surname><given-names>VN</given-names></name><name><surname>Suchard</surname><given-names>MA</given-names></name></person-group><article-title>Counting labeled transitions in continuous-time Markov models of evolution</article-title><source>Journal of mathematical biology</source><year>2008</year><volume>56</volume><fpage>391</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1007/s00285-007-0120-8</pub-id><?supplied-pmid 17874105?><pub-id pub-id-type="pmid">17874105</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bielejec</surname><given-names>F</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name><name><surname>Suchard</surname><given-names>MA</given-names></name><name><surname>Lemey</surname><given-names>P</given-names></name></person-group><article-title>SPREAD: spatial phylogenetic reconstruction of evolutionary dynamics</article-title><source>Bioinformatics (Oxford, England)</source><year>2011</year><volume>27</volume><fpage>2910</fpage><lpage>2912</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr481</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">Drummond, A. J. &#x00026; Bouckaert, R. R. Bayesian evolutionary analysis with BEAST. (Cambridge University Press., 2017).</mixed-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kass</surname><given-names>RE</given-names></name><name><surname>Raftery</surname><given-names>AE</given-names></name></person-group><article-title>Bayes Factors</article-title><source>Journal of the American Statistical Association</source><year>1995</year><volume>90</volume><fpage>773</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1080/01621459.1995.10476572</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Team, R.C. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL <ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/">http://www.R-project.org/</ext-link>. (2013).</mixed-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>T</given-names></name><name><surname>Guenther</surname><given-names>W</given-names></name><name><surname>Trevor</surname><given-names>H</given-names></name></person-group><article-title>Estimating the number of clusters in a data set via the gap statistic</article-title><source>Journal of the Royal Statistical Society: Series B (Statistical Methodology)</source><year>2001</year><volume>63</volume><fpage>411</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1111/1467-9868.00293</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci</article-title><source>Molecular biology and evolution</source><year>2013</year><volume>30</volume><fpage>713</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1093/molbev/mss265</pub-id><?supplied-pmid 23180580?><pub-id pub-id-type="pmid">23180580</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agwale</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials</article-title><source>Vaccine</source><year>2002</year><volume>20</volume><fpage>2131</fpage><lpage>2139</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(02)00059-2</pub-id><?supplied-pmid 11972982?><pub-id pub-id-type="pmid">11972982</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hue</surname><given-names>S</given-names></name><name><surname>Clewley</surname><given-names>JP</given-names></name><name><surname>Cane</surname><given-names>PA</given-names></name><name><surname>Pillay</surname><given-names>D</given-names></name></person-group><article-title>HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy</article-title><source>AIDS</source><year>2004</year><volume>18</volume><fpage>719</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1097/00002030-200403260-00002</pub-id><?supplied-pmid 15075506?><pub-id pub-id-type="pmid">15075506</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peeters</surname><given-names>M</given-names></name><etal/></person-group><article-title>Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution</article-title><source>AIDS Res Hum Retroviruses</source><year>2000</year><volume>16</volume><fpage>315</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1089/088922200309197</pub-id><?supplied-pmid 10716369?><pub-id pub-id-type="pmid">10716369</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delatorre</surname><given-names>E</given-names></name><name><surname>Mir</surname><given-names>D</given-names></name><name><surname>Bello</surname><given-names>G</given-names></name></person-group><article-title>Spatiotemporal dynamics of the HIV-1 subtype G epidemic in West and Central Africa</article-title><source>PloS one</source><year>2014</year><volume>9</volume><fpage>e98908</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0098908</pub-id><?supplied-pmid 24918930?><pub-id pub-id-type="pmid">24918930</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>J</given-names></name><etal/></person-group><article-title>Identification of new CRF43_02G and CRF25_cpx in Saudi Arabia based on full genome sequence analysis of six HIV type 1 isolates</article-title><source>AIDS Res Hum Retroviruses</source><year>2008</year><volume>24</volume><fpage>1327</fpage><lpage>1335</lpage><pub-id pub-id-type="doi">10.1089/aid.2008.0101</pub-id><?supplied-pmid 18844465?><pub-id pub-id-type="pmid">18844465</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faria</surname><given-names>NR</given-names></name><etal/></person-group><article-title>Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon</article-title><source>Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases</source><year>2012</year><volume>12</volume><fpage>453</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2011.04.028</pub-id><?supplied-pmid 21565285?><pub-id pub-id-type="pmid">21565285</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>AB</given-names></name><name><surname>Vandamme</surname><given-names>AM</given-names></name><name><surname>Lemey</surname><given-names>P</given-names></name></person-group><article-title>Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution</article-title><source>Journal of virology</source><year>2009</year><volume>83</volume><fpage>12917</fpage><lpage>12924</lpage><pub-id pub-id-type="doi">10.1128/JVI.01022-09</pub-id><?supplied-pmid 19793809?><pub-id pub-id-type="pmid">19793809</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mir</surname><given-names>D</given-names></name><etal/></person-group><article-title>Phylodynamics of the major HIV-1 CRF02_AG African lineages and its global dissemination</article-title><source>Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases</source><year>2016</year><volume>46</volume><fpage>190</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2016.05.017</pub-id><?supplied-pmid 27180893?><pub-id pub-id-type="pmid">27180893</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>TM</given-names></name><name><surname>Rasheed</surname><given-names>S</given-names></name></person-group><article-title>Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria</article-title><source>AIDS Res Hum Retroviruses</source><year>1996</year><volume>12</volume><fpage>1413</fpage><lpage>1425</lpage><pub-id pub-id-type="doi">10.1089/aid.1996.12.1413</pub-id><?supplied-pmid 8893049?><pub-id pub-id-type="pmid">8893049</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esbjornsson</surname><given-names>J</given-names></name><name><surname>Mild</surname><given-names>M</given-names></name><name><surname>Mansson</surname><given-names>F</given-names></name><name><surname>Norrgren</surname><given-names>H</given-names></name><name><surname>Medstrand</surname><given-names>P</given-names></name></person-group><article-title>HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations</article-title><source>PloS one</source><year>2011</year><volume>6</volume><fpage>e17025</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0017025</pub-id><?supplied-pmid 21365013?><pub-id pub-id-type="pmid">21365013</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots</article-title><source>Journal of virology</source><year>2002</year><volume>76</volume><fpage>11273</fpage><lpage>11282</lpage><pub-id pub-id-type="doi">10.1128/JVI.76.22.11273-11282.2002</pub-id><?supplied-pmid 12388687?><pub-id pub-id-type="pmid">12388687</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magiorkinis</surname><given-names>G</given-names></name><etal/></person-group><article-title><italic>In vivo</italic> characteristics of human immunodeficiency virus type 1 intersubtype recombination: determination of hot spots and correlation with sequence similarity</article-title><source>J. Gen Virol.</source><year>2003</year><volume>84</volume><fpage>2715</fpage><lpage>2722</lpage><pub-id pub-id-type="doi">10.1099/vir.0.19180-0</pub-id><?supplied-pmid 13679605?><pub-id pub-id-type="pmid">13679605</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galli</surname><given-names>A</given-names></name><etal/></person-group><article-title>Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms</article-title><source>J. Gen Virol.</source><year>2008</year><volume>89</volume><fpage>3119</fpage><lpage>3125</lpage><pub-id pub-id-type="doi">10.1099/vir.0.2008/003418-0</pub-id><?supplied-pmid 19008401?><pub-id pub-id-type="pmid">19008401</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Identifying recombination hot spots in the HIV-1 genome</article-title><source>Journal of virology</source><year>2014</year><volume>88</volume><fpage>2891</fpage><lpage>2902</lpage><pub-id pub-id-type="doi">10.1128/JVI.03014-13</pub-id><?supplied-pmid 24371048?><pub-id pub-id-type="pmid">24371048</pub-id></element-citation></ref></ref-list></back></article>